The firm increased its portfolio allocation in GSK by 13.25% over the last quarter. GSK Background Information (This description is provided by the company.) GSK is a science-led global healthcare ...

GlaxoSmithKline chief executive Emma Walmsley ... experience" – which may be an oblique reference to Walmsley's background in consumer health. According to the latter, shareholders "still ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. GSK is nearing a $1bn deal to buy a US biotech developing a treatment for rare gastrointestinal tumours ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other FTSE dividend stocks. Goldman Sachs Research predicts moderate growth for the UK economy in 2025 ...